198 related articles for article (PubMed ID: 30044303)
1. Effect of Racial Inequities in Pre-exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex With Men: A Modeling Study.
Goedel WC; King MRF; Lurie MN; Nunn AS; Chan PA; Marshall BDL
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):323-329. PubMed ID: 30044303
[TBL] [Abstract][Full Text] [Related]
2. Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
Jenness SM; Maloney KM; Smith DK; Hoover KW; Goodreau SM; Rosenberg ES; Weiss KM; Liu AY; Rao DW; Sullivan PS
Am J Epidemiol; 2019 Apr; 188(4):743-752. PubMed ID: 30312365
[TBL] [Abstract][Full Text] [Related]
3. Projecting the impact of equity-based preexposure prophylaxis implementation on racial disparities in HIV incidence among MSM.
Goedel WC; Bessey S; Lurie MN; Biello KB; Sullivan PS; Nunn AS; Marshall BDL
AIDS; 2020 Aug; 34(10):1509-1517. PubMed ID: 32384282
[TBL] [Abstract][Full Text] [Related]
4. Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
Marshall BDL; Goedel WC; King MRF; Singleton A; Durham DP; Chan PA; Townsend JP; Galvani AP
Lancet HIV; 2018 Sep; 5(9):e498-e505. PubMed ID: 29908917
[TBL] [Abstract][Full Text] [Related]
5. Achieving the "Ending the HIV Epidemic in the U.S." incidence reduction goals among at-risk populations in the South.
Hamilton DT; Hoover KW; Smith DK; Delaney KP; Wang LY; Li J; Hoyte T; Jenness SM; Goodreau SM
BMC Public Health; 2023 Apr; 23(1):716. PubMed ID: 37081482
[TBL] [Abstract][Full Text] [Related]
6. Estimating HIV protective effects of method adherence with combinations of preexposure prophylaxis and condom use among African American men who have sex with men.
Smith DK; Herbst JH; Rose CE
Sex Transm Dis; 2015 Feb; 42(2):88-92. PubMed ID: 25585067
[TBL] [Abstract][Full Text] [Related]
7. Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men - 23 Urban Areas, 2017.
Kanny D; Jeffries WL; Chapin-Bardales J; Denning P; Cha S; Finlayson T; Wejnert C;
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(37):801-806. PubMed ID: 31536484
[TBL] [Abstract][Full Text] [Related]
8. Added Benefits of Pre-Exposure Prophylaxis Use on HIV Incidence with Minimal Changes in Efficiency in the Context of High Treatment Engagement Among Men Who Have Sex with Men.
Singleton AL; Marshall BDL; Zang X; Nunn AS; Goedel WC
AIDS Patient Care STDS; 2020 Dec; 34(12):506-515. PubMed ID: 33216618
[TBL] [Abstract][Full Text] [Related]
9. Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study.
Gantenberg JR; King M; Montgomery MC; Galárraga O; Prosperi M; Chan PA; Marshall BDL
PLoS One; 2018; 13(7):e0199915. PubMed ID: 29985949
[TBL] [Abstract][Full Text] [Related]
10. Using Microsimulation Modeling to Inform EHE Implementation Strategies in Los Angeles County.
Drabo EF; Moucheraud C; Nguyen A; Garland WH; Holloway IW; Leibowitz A; Suen SC
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S167-S176. PubMed ID: 35703769
[TBL] [Abstract][Full Text] [Related]
11. Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.
Jenness SM; Goodreau SM; Rosenberg E; Beylerian EN; Hoover KW; Smith DK; Sullivan P
J Infect Dis; 2016 Dec; 214(12):1800-1807. PubMed ID: 27418048
[TBL] [Abstract][Full Text] [Related]
12. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
[TBL] [Abstract][Full Text] [Related]
13. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England.
Mitchell HD; Desai S; Mohammed H; Ong KJ; Furegato M; Hall V; Desai M; Saunders JM; Hughes G; Field N; Gill ON
Sex Transm Infect; 2019 Nov; 95(7):484-487. PubMed ID: 31010953
[TBL] [Abstract][Full Text] [Related]
14. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
[TBL] [Abstract][Full Text] [Related]
15. Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
Lyons CE; Stokes-Cawley OJ; Simkin A; Bowring AL; Mfochive Njindam I; Njoya O; Bissek AZ; Tamoufe U; Georges S; Kakanou FZ; Turpin G; Levitt D; Billong SC; Mishra S; Baral S
BMC Infect Dis; 2022 Sep; 22(1):751. PubMed ID: 36163000
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.
Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES
Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240
[TBL] [Abstract][Full Text] [Related]
17. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
[TBL] [Abstract][Full Text] [Related]
18. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA;
Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026
[TBL] [Abstract][Full Text] [Related]
19. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015.
Smith DK; Van Handel M; Grey J
Ann Epidemiol; 2018 Dec; 28(12):850-857.e9. PubMed ID: 29941379
[TBL] [Abstract][Full Text] [Related]
20. Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States.
Elion RA; Kabiri M; Mayer KH; Wohl DA; Cohen J; Beaubrun AC; Altice FL
Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31067679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
